StemCell Institute Inc. (TYO:7096)
Japan · Delayed Price · Currency is JPY 730.00
0.00 (0.00%)
Aug 6, 2026, 12:30 PM JST
StemCell Institute Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 217 | 565 | 441 | 278 | 212 |
Depreciation & Amortization | 156 | 128 | 120 | 104 | 96 |
Loss (Gain) From Sale of Investments | - | -136 | -22 | - | - |
Other Operating Activities | -184 | -148 | -111 | -108 | 11 |
Change in Accounts Receivable | -496 | -252 | -447 | -546 | -314 |
Change in Inventory | -3 | -8 | -2 | - | -8 |
Change in Accounts Payable | 4 | -21 | 18 | -10 | 72 |
Change in Other Net Operating Assets | 379 | 339 | 337 | 381 | 400 |
Operating Cash Flow | 73 | 467 | 334 | 99 | 469 |
Operating Cash Flow Growth | -84.37% | 39.82% | 237.37% | -78.89% | 97.06% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -409 | -478 | -183 | -56 | -181 |
Cash Acquisitions | - | -34 | - | - | - |
Sale (Purchase) of Intangibles | -117 | -96 | -18 | -3 | -23 |
Investment in Securities | -200 | 357 | -627 | -142 | 750 |
Other Investing Activities | -18 | -9 | 17 | -84 | -142 |
Investing Cash Flow | -744 | -259 | -811 | -285 | 404 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | - | 510 | - | - | - |
Long-Term Debt Repaid | -63 | -11 | - | - | - |
Net Debt Issued (Repaid) | -63 | 499 | - | - | - |
Issuance of Common Stock | - | - | - | - | 644 |
Repurchase of Common Stock | -106 | -94 | - | - | - |
Common Dividends Paid | - | -255 | - | - | - |
Other Financing Activities | 400 | -4 | -1 | - | - |
Financing Cash Flow | 231 | 146 | -1 | - | 644 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | 35 | - | - | - | - |
Miscellaneous Cash Flow Adjustments | 1 | 1 | - | - | - |
Net Cash Flow | -404 | 355 | -478 | -186 | 1,517 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -336 | -11 | 151 | 43 | 288 |
Free Cash Flow Growth | - | - | 251.16% | -85.07% | - |
Free Cash Flow Margin | -11.95% | -0.41% | 6.09% | 2.06% | 16.17% |
Free Cash Flow Per Share | -33.27 | -1.07 | 14.74 | 4.20 | 56.87 |
Levered Free Cash Flow | -543.25 | 7.25 | 56.75 | 56.25 | 236.88 |
Unlevered Free Cash Flow | -540.13 | 7.88 | 56.75 | 56.25 | 236.88 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 5 | 1 | - | - | - |
Cash Income Tax Paid | 184 | 144 | 110 | 109 | -8 |
Change in Working Capital | -116 | 58 | -94 | -175 | 150 |